What is the long-term trend for Vivani Medical's operating loss carryforwards valuation allowance?

Over 3 years (2022 to 2025), Vivani Medical's operating loss carryforwards valuation allowance has grown at a 7.8% compound annual growth rate (CAGR), from $4.98M to $6.25M.

Vivani Medical VANI Operating Loss Carryforwards Valuation Allowance

Other financials

Income statement

See full

Revenue-—

Gross profit$130.0K—

Operating income-$6.8M-4.0%

Net income-$6.8M-7.6%

EPS (diluted)-$0.08+27.3%

Balance sheet

See full

Cash & equivalents$19.0M+57.7%

Total debt$18.3M-3.5%

Total equity$19.1M+64.2%

Total assets$42.4M+19.5%

Cash flow

See full

Operating cash flow-$6.2M-20.0%

CapEx$3.0K-40.0%

Free cash flow-$6.2M-19.9%

Valuation

See full

Market cap$106.93M+40.0%

Enterprise value$106.17M+19.3%

Profitability

See full

Gross margin36.3%—

Operating margin-1,004.9%—

Net margin-994.1%—

FCF margin-832.3%—

Returns & leverage

See full

Return on equity-176.4%+175pp

Debt / equity1×-0.7×

Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:OperatingLossCarryforwardsValuationAllowance.

The official record: Vivani Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's operating loss carryforwards valuation allowance.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vivani Medical's operating loss carryforwards valuation allowance?: Vivani Medical (VANI) reported operating loss carryforwards valuation allowance of $6.25M in Q4 2025.
What is the long-term trend for Vivani Medical's operating loss carryforwards valuation allowance?: Over 3 years (2022 to 2025), Vivani Medical's operating loss carryforwards valuation allowance has grown at a 7.8% compound annual growth rate (CAGR), from $4.98M to $6.25M.